title: [GnRH analogs versus gestagens in therapy of endometriosis].
authors.affiliation: 1. Universitäts-Frauenklinik, Wien, Osterreich.
authors.forename: R
authors.initials: R
authors.lastname: Wenzl
authors.forename: B
authors.initials: B
authors.lastname: Schurz
authors.forename: G
authors.initials: G
authors.lastname: Freude
authors.forename: J
authors.initials: J
authors.lastname: Huber
mesh_terms: D000328:Adult; D003692:Delayed-Action Preparations; D004715:Endometriosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008234:Lynestrenol / Q000008:administration & dosage* / Q000009:adverse effects; D017329:Triptorelin Pamoate / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D003692:Delayed-Action Preparations; D017329:Triptorelin Pamoate; D008234:Lynestrenol
vernacular_title: GnRH-Analoga versus Gestagene bei der Endometriosetherapie.